Pharmaceutical

RT-002 by Revance Therapeutics for Upper Limb Muscle Sp...

RT-002 is under clinical development by Revance Therapeutics and currently in Ph...

Pimitespib by Otsuka Pharmaceutical for Metastatic Lung...

Pimitespib is under clinical development by Otsuka Pharmaceutical and currently ...

NuGel by Shaperon for Sepsis: Likelihood of Approval

NuGel is under clinical development by Shaperon and currently in Phase I for Sep...

TAS-117 by Taiho Pharmaceutical for Chondrosarcoma: Lik...

TAS-117 is under clinical development by Taiho Pharmaceutical and currently in P...

VEDVDox by ImmunityBio for Recurrent Glioblastoma Multi...

VEDVDox is under clinical development by ImmunityBio and currently in Phase I fo...

CIGB-128 by Center for Genetic Engineering and Biotechn...

CIGB-128 is under clinical development by Center for Genetic Engineering and Bio...

Influenza vaccine 2 by Shanghai Institute of Biological...

Influenza vaccine 2 is under clinical development by Shanghai Institute of Biolo...

PB-357 by Puma Biotechnology for Breast Cancer: Likelih...

PB-357 is under clinical development by Puma Biotechnology and currently in Phas...

RZ-358 by Rezolute for Hyperinsulinemia: Likelihood of ...

RZ-358 is under clinical development by Rezolute and currently in Phase II for H...

STAT+: Chamber of Commerce tries new legal arguments to...

The Chamber of Commerce lawsuit is the second to challenge the drug-price negoti...

Top health officials call for more research to support ...

Research on the most effective use of fentanyl test strips could be useful as ot...

STAT+: FDA panel unanimously endorses Eisai’s Alzheimer...

The vote in favor of expanding the approval of Alzheimer's treatment Leqembi fur...

STAT+: Drug companies and pharmacies reach $17.3 billio...

Drug companies and pharmacies have reached a $17.3 billion settlement over the o...

FDA’s letter to medical device maker iRhythm is a warni...

The FDA issued a warning to device maker iRhythm for marketing its product for “...

STAT+: ‘Stung’ by Pear’s bankruptcy, a state Medicaid p...

"It would be hard for me to convince my leadership to take that leap again so so...

Opinion: Why we created a chatbot to help people at ris...

The grim reality is there will never be enough trained therapists to meet the de...